StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)

Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –

Nephros net income

Net income is the profit left for shareholders after every expense, interest and tax.

Nephros's net income for the twelve months ending Jun 30, 2026 was $1.74M, up 30.8% year over year. For fiscal 2025 it was $1.19M, up 1513.5% from the year before. The highest annual figure on record is $3.88M in fiscal 2010.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.19M+1513.5%
FY2024Dec 31, 2024$74.00K–
FY2023Dec 31, 2023-$1.58M–
FY2021Dec 31, 2021-$3.87M–
FY2020Dec 31, 2020-$4.53M–
FY2019Dec 31, 2019-$3.18M–
FY2018Dec 31, 2018-$3.40M–
FY2017Dec 31, 2017-$809.00K–
FY2016Dec 31, 2016-$3.03M–
FY2015Dec 31, 2015-$3.09M–
FY2014Dec 31, 2014-$7.37M-657.6%
FY2013Dec 31, 2013$1.32M–
FY2012Dec 31, 2012-$6.62M–
FY2011Dec 31, 2011-$7.00M-280.4%
FY2010Dec 31, 2010$3.88M–
FY2009Dec 31, 2009-$12.08M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.20M+405.1%
Q1 FY2026Mar 31, 2026$140.00K-74.9%
Q4 FY2025Dec 31, 2025$62.00K-82.2%
Q3 FY2025Sep 30, 2025$337.00K+84.2%
Q2 FY2025Jun 30, 2025$237.00K–
Q1 FY2025Mar 31, 2025$558.00K–
Q4 FY2024Dec 31, 2024$349.00K–
Q3 FY2024Sep 30, 2024$183.00K–
Q2 FY2024Jun 30, 2024-$289.00K–
Q1 FY2024Mar 31, 2024-$169.00K–
Q4 FY2023Dec 31, 2023-$654.00K–
Q3 FY2023Sep 30, 2023-$182.00K–
Q2 FY2023Jun 30, 2023-$433.00K–
Q1 FY2023Mar 31, 2023-$306.00K–
Q3 FY2022Sep 30, 2022-$3.23M–
Q2 FY2022Jun 30, 2022-$1.14M–
Q1 FY2022Mar 31, 2022-$1.97M–
Q4 FY2021Dec 31, 2021-$863.00K–
Q3 FY2021Sep 30, 2021-$1.22M–
Q2 FY2021Jun 30, 2021-$1.13M–
Q1 FY2021Mar 31, 2021-$537.00K–
Q4 FY2020Dec 31, 2020-$759.00K–
Q3 FY2020Sep 30, 2020-$1.01M–
Q2 FY2020Jun 30, 2020-$1.66M–
Q1 FY2020Mar 31, 2020-$1.10M–
Q4 FY2019Dec 31, 2019-$144.00K–
Q3 FY2019Sep 30, 2019-$744.00K–
Q2 FY2019Jun 30, 2019-$942.00K–
Q1 FY2019Mar 31, 2019-$1.35M–
Q4 FY2018Dec 31, 2018-$725.00K-156.2%
Q3 FY2018Sep 30, 2018-$566.00K–
Q2 FY2018Jun 30, 2018-$682.00K–
Q1 FY2018Mar 31, 2018-$1.43M–
Q4 FY2017Dec 31, 2017$1.29M–
Q3 FY2017Sep 30, 2017-$632.00K–
Q2 FY2017Jun 30, 2017-$786.00K–
Q1 FY2017Mar 31, 2017-$680.00K–
Q4 FY2016Dec 31, 2016-$655.00K–
Q3 FY2016Sep 30, 2016-$706.00K–

More Nephros figures

See a number that looks wrong?